Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In this review, we discussed current SCD therapeutics and the specific stages of pathophysiology they target
GIP receptor agonism further augments insulin release and may influence fat metabolism, though the precise contribution of GIP receptor activation to clinical outcomes in humans remains an area of active investigation
AOD-9604, short for Anti-Obesity Drug-9604, is a synthetic analog of the human growth hormones lipolytic (fat-burning) region
Mitochondrial dysfunction and oxidative stress: Cause and consequence of epileptic seizures
US$ 29.86
US$ 25.22
US$ 20.63
US$ 23.82
